View Author
marrow patient imaging activity bone marrow treatment liver therapy tumour uptake dosimetry study receptor spect somatostatin 111 in-dtpa-d-phe 1-octreotide radiation yttrium blood 90 y-dota-d-phe 1-tyr microsphere kidney 68 ga radioactivity cancer 1-tyr tumours peptide method y-dota-d-phe result 1-octreotide 68 ga-labeled pharmaceuticals in-dtpa-d-phe medicine generator radionuclide hepatic organ biodistribution bone marrow aspirate 90 y-microspheres tissue volume 131 i-lipiodol tumor administration ga-labeled toxicity bremsstrahlung -90 response emission hepatocellular carcinoma bone marrow dosimetry antibody sir-spheres ® 86 y-dota-d-phe 1-tyr y-microsphere count pet imaging correction comparison sir-sphere procedure value ratio positron emission tomography octreotide application analogue therasphere sphere artery i-lipiodol /68ga cell fraction lu-dota jong m remainder
5 Most Recent Publications
|
68Ga-labeled DOTA-peptides and
68Ga-labeled radiopharmaceuticals for positron emission tomography: Current status of research, clinical applications, and future Perspectives
(Article)
Breeman, W.A.P. Blois, E. de Sze Chan, H. Konijnenberg, M. Kwekkeboom, D.J. Krenning, E.P. |
2011-07-01
|
|
EANM procedure guideline for the treatment of liver cancer and liver metastases with intra-arterial radioactive compounds
(Article)
Giammarile, F. Bodei, L. Tennvall, J. Luster, M. Chiesa, C. Flux, G. Forrer, F. Kraeber-Bodere, F. Brans, B. Lambert, B. Konijnenberg, M. Borson-Chazot, F. |
2011-07-01
|
|
Dosimetry of yttrium-labelled radiopharmaceuticals for internal therapy:
86Y or
90Y imaging?
(Article)
Walrand, S. Flux, G. Konijnenberg, M. Valkema, R. Krenning, E.P. Lhommel, R. Pauwels, S. Jamar, F. |
2011-05-01
|
|
Bone marrow dosimetry in peptide receptor radionuclide therapy with [ 177Lu-DOTA0,Tyr3]octreotate
(Article)
Forrer, F. Krenning, E.P. Kwekkeboom, D. Kooij, P.P.M. Bernard, B.F. Konijnenberg, M. Bakker, W.H. Teunissen, J.J.M. Jong, M. de Lom, K. van Herder, W.W. de |
2009-07-01
|
|
Therapy using labelled somatostatin analogues: Comparison of the absorbed doses with 111In-DTPA-D-Phe1-octreotide and yttrium-labelled DOTA-D-Phe1-Tyr3-octreotide
(Article)
Barone, R. Walrand, S. Konijnenberg, M. Valkema, R. Kvols, L.K. Krenning, E.P. Pauwels, S. Jamar, F. |
2008-03-01
|